SMNR (Semnur Pharmaceuticals) Days Payable: 0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SMNR Semnur Pharmaceuticals Inc SMNR
10 GF Score
Price $0.67
! 1 Warning Sign
View Full Analysis

What is Semnur Pharmaceuticals Days Payable?

Semnur Pharmaceuticals SMNR +0.01% 10 Days Payable is 0.00 as of Jun. 2026. GuruFocus rates SMNR with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 704 Biotechnology companies, Semnur Pharmaceuticals ranks worse than 142045.31% on this metric.

Semnur Pharmaceuticals's average Accounts Payable for the three months ended in Jun. 2026 was $6.67 Mil. Semnur Pharmaceuticals's Cost of Goods Sold for the three months ended in Jun. 2026 was $0.00 Mil.

The historical rank and industry rank for Semnur Pharmaceuticals's Days Payable or its related term are showing as below:

SMNR's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 110.01
* Ranked among companies with meaningful Days Payable only.

Semnur Pharmaceuticals's Days Payable stayed the same from Jun. 2025 (0.00) to Jun. 2026 (0.00). stayed the same

Semnur Pharmaceuticals Days Payable Historical Data

* Premium members only.

The historical data trend for Semnur Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Semnur Pharmaceuticals Days Payable Chart

Semnur Pharmaceuticals Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Days Payable
0.00 0.00 0.00 0.00

Semnur Pharmaceuticals Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SMNR vs ARCT, CRBU, EQ: Days Payable Comparison

For the Biotechnology subindustry, Semnur Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Semnur Pharmaceuticals Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Semnur Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Semnur Pharmaceuticals's Days Payable falls into.


SMNR
10GF Score
Semnur Pharmaceuticals Inc SMNR
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Semnur Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Semnur Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0 + 5.912) / 1 ) / 0*365
=5.912 / 0*365
=N/A

Semnur Pharmaceuticals's Days Payable for the quarter that ended in Jun. 2026 is calculated as:

Days Payable (Q: Jun. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Mar. 2026 ) + Accounts Payable (Q: Jun. 2026 )) / count ) / Cost of Goods Sold (Q: Jun. 2026 )*Days in Period
=( (6.423 + 6.918) / 2 ) / 0*365 / 4
=6.6705 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Semnur Pharmaceuticals (SMNR) has a Days Payable of 0.00 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Semnur Pharmaceuticals and its competitors. According to the industry distribution chart, Semnur Pharmaceuticals ranks #999999 out of 704 companies in the Biotechnology industry.
Is Semnur Pharmaceuticals' Days Payable too high?
Semnur Pharmaceuticals' current Days Payable is 0.00. Based on the distribution chart, Semnur Pharmaceuticals ranks #999999 out of 704 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Semnur Pharmaceuticals has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Semnur Pharmaceuticals' Days Payable compare to ARCT and CRBU?
According to the Biotechnology industry distribution chart, Semnur Pharmaceuticals ranks #999999 out of 704 companies for Days Payable. This places Semnur Pharmaceuticals in the lower half of its industry. The industry median Days Payable is 110.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 110.01, based on 704 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Semnur Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Payable is 110.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Semnur Pharmaceuticals's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Semnur Pharmaceuticals stock overvalued right now?
Semnur Pharmaceuticals (SMNR) has a current Days Payable of 0.00. The current Days Payable is 0.00. Semnur Pharmaceuticals' overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Semnur Pharmaceuticals (SMNR), the current Days Payable is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Semnur Pharmaceuticals Business Description

Address 960 San Antonio Road, Palo Alto, CA, USA, 94303
Semnur Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its main product candidate, SP-102 (10 mg, dexamethasone sodium phosphate viscous gel), is being developed as a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe LRP (also known as sciatica), containing no preservatives, surfactants, solvents, or particulates.
10GF Score

Get the complete analysis for SMNR

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.67
Price